<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7219724\results\search\disease\results.xml">
  <result pre="MSM-32-71 doi: 10.5455/msm.2020.32.71-76 : Review Public Health Aspects of COVID-19" exact="Infection" post="with Focus on Cardiovascular Diseases MasicIzet1NaserNabil2ZildzicMuharem1[1], [2], Corresponding author:"/>
  <result pre="Review Public Health Aspects of COVID-19 Infection with Focus on" exact="Cardiovascular Diseases" post="MasicIzet1NaserNabil2ZildzicMuharem1[1], [2], Corresponding author: Izet Masic, MD, PhD. Full"/>
  <result pre="Public Health Aspects of COVID-19 Infection with Focus on Cardiovascular" exact="Diseases" post="MasicIzet1NaserNabil2ZildzicMuharem1[1], [2], Corresponding author: Izet Masic, MD, PhD. Full"/>
  <result pre="original work is properly cited. Abstract Introduction: COVID-19 is the" exact="disease" post="caused by an infection of the SARS-CoV-2 virus, first"/>
  <result pre="cited. Abstract Introduction: COVID-19 is the disease caused by an" exact="infection" post="of the SARS-CoV-2 virus, first identified in the city"/>
  <result pre="2019. COVID-19 was previously known as 2019 Novel Coronavirus (2019-nCoV)" exact="respiratory" post="disease before the World Health Organization (WHO) declared the"/>
  <result pre="COVID-19 was previously known as 2019 Novel Coronavirus (2019-nCoV) respiratory" exact="disease" post="before the World Health Organization (WHO) declared the official"/>
  <result pre="investigations regarding morbidity and mortality rates as consequences of COVID-19" exact="infection" post="of Cardiovascular diseases (CVD), and other most common chronic"/>
  <result pre="COVID-19 infection of Cardiovascular diseases (CVD), and other most common" exact="chronic" post="diseases which are on the top mortality and morbidity"/>
  <result pre="5 months from the time when first cases of COVID-10" exact="infection" post="was detected. Also, there is no unique proposed ways"/>
  <result pre="in Strategic documents of WHO, in statements of Declaration of" exact="Primary" post="Health Care in Alma Ata in 1978. Conclusion: WHO"/>
  <result pre="at every level of Health Care Systems, but especially at" exact="primary" post="health care level, must follow those recommendations and teach"/>
  <result pre="could be bigger challenge for Global Public Health. COVID-19 CVDs" exact="Chronic" post="diseases Public health Post-coronavirus Stress Syndrome - PCSS WHO"/>
  <result pre="Public Health. COVID-19 CVDs Chronic diseases Public health Post-coronavirus Stress" exact="Syndrome" post="- PCSS WHO Guidelines 1. INTRODUCTION COVID-19 is the"/>
  <result pre="Syndrome - PCSS WHO Guidelines 1. INTRODUCTION COVID-19 is the" exact="disease" post="caused by an infection of the SARS-CoV-2 virus, first"/>
  <result pre="Guidelines 1. INTRODUCTION COVID-19 is the disease caused by an" exact="infection" post="of the SARS-CoV-2 virus, first identified in the city"/>
  <result pre="2019. COVID-19 was previously known as 2019 Novel Coronavirus (2019-nCoV)" exact="respiratory" post="disease before the World Health Organization (WHO) declared the"/>
  <result pre="COVID-19 was previously known as 2019 Novel Coronavirus (2019-nCoV) respiratory" exact="disease" post="before the World Health Organization (WHO) declared the official"/>
  <result pre="the official name as COVID-19 in February 2020. A new" exact="respiratory" post="disease - Coronavirus disease 2019 (COVID-19) - is spreading"/>
  <result pre="official name as COVID-19 in February 2020. A new respiratory" exact="disease" post="- Coronavirus disease 2019 (COVID-19) - is spreading globally"/>
  <result pre="COVID-19 in February 2020. A new respiratory disease - Coronavirus" exact="disease" post="2019 (COVID-19) - is spreading globally and there have"/>
  <result pre="spread in the United States. COVID-19 spreads by contact with" exact="respiratory" post="droplets that spread when an infected person coughs or"/>
  <result pre="droplets that spread when an infected person coughs or sneezes." exact="Respiratory" post="virus infection is a major source of global pandemics"/>
  <result pre="that spread when an infected person coughs or sneezes. Respiratory" exact="virus infection" post="is a major source of global pandemics as a"/>
  <result pre="spread when an infected person coughs or sneezes. Respiratory virus" exact="infection" post="is a major source of global pandemics as a"/>
  <result pre="source of global pandemics as a consequence of swift human-to-human" exact="respiratory" post="tract transmission. Within the past two decades, coronaviruses and"/>
  <result pre="2254 patients in 27 countries (1). Besides coronaviruses, avian and" exact="swine influenza" post="remain a concern for global public health in the"/>
  <result pre="18 500 laboratory-confirmed deaths and more than 200.000 deaths from" exact="respiratory" post="disease worldwide (2). In late 2019, a cohort of"/>
  <result pre="500 laboratory-confirmed deaths and more than 200.000 deaths from respiratory" exact="disease" post="worldwide (2). In late 2019, a cohort of patients"/>
  <result pre="(2). In late 2019, a cohort of patients presenting with" exact="pneumonia" post="of varying acuity and unknown aetiology in Wuhan, China,"/>
  <result pre="Wuhan, China, heralded the outset of COVID-19. As of 30.03.2020," exact="total" post="of 770,165 confirmed cases (including 36,938 deaths in 152"/>
  <result pre="still increasing. Although COVID-19 appears to have greater infectivity and" exact="lower" post="mortality than SARS and MERS, many uncertainties (including route"/>
  <result pre="than SARS and MERS, many uncertainties (including route of infection," exact="viral" post="evolution, epidemic dynamics, appropriate anti-viral treatment, and strategies for"/>
  <result pre="viral evolution, epidemic dynamics, appropriate anti-viral treatment, and strategies for" exact="disease" post="control) remain. On March 11, 2020, the WHO declared"/>
  <result pre="a pandemic (3). Since there is no cure for this" exact="viral" post="disease and a long wait is needed to find"/>
  <result pre="pandemic (3). Since there is no cure for this viral" exact="disease" post="and a long wait is needed to find a"/>
  <result pre="are justified, as experts point to procedures that curb a" exact="Severe" post="Acute Respiratory Syndrome (SARS) caused by another type of"/>
  <result pre="justified, as experts point to procedures that curb a Severe" exact="Acute" post="Respiratory Syndrome (SARS) caused by another type of virus"/>
  <result pre="as experts point to procedures that curb a Severe Acute" exact="Respiratory" post="Syndrome (SARS) caused by another type of virus Corona."/>
  <result pre="experts point to procedures that curb a Severe Acute Respiratory" exact="Syndrome" post="(SARS) caused by another type of virus Corona. 2."/>
  <result pre="Corona. 2. CONSEQUENCES OF COVID-19 ON CVD AND OTHER COMMON" exact="CHRONIC" post="DISEASES Cardiovascular complications of influenza infection, including myocarditis, acute"/>
  <result pre="COMMON CHRONIC DISEASES Cardiovascular complications of influenza infection, including myocarditis," exact="acute" post="myocardial infarction, and exacerbation of heart failure have been"/>
  <result pre="CHRONIC DISEASES Cardiovascular complications of influenza infection, including myocarditis, acute" exact="myocardial infarction," post="and exacerbation of heart failure have been well-recognized during"/>
  <result pre="influenza infection, including myocarditis, acute myocardial infarction, and exacerbation of" exact="heart" post="failure have been well-recognized during previous historical epidemics and"/>
  <result pre="corona-virus outbreaks have been associated with a significant burden of" exact="cardiovascular" post="comorbidities and complications. Furthermore, the severity of the primary"/>
  <result pre="of cardiovascular comorbidities and complications. Furthermore, the severity of the" exact="primary" post="respiratory syndrome and risk of adverse outcomes is increased"/>
  <result pre="cardiovascular comorbidities and complications. Furthermore, the severity of the primary" exact="respiratory" post="syndrome and risk of adverse outcomes is increased in"/>
  <result pre="comorbidities and complications. Furthermore, the severity of the primary respiratory" exact="syndrome" post="and risk of adverse outcomes is increased in patients"/>
  <result pre="risk of adverse outcomes is increased in patients with pre-existing" exact="cardiovascular" post="diseases (5, 6). Hypotension, tachycardia, bradycardia, arrhythmia, or even"/>
  <result pre="mortality - up to 50% of hospitalized patients have a" exact="chronic" post="medical illness (40% cardiovascular or cerebrovascular disease). In the"/>
  <result pre="50% of hospitalized patients have a chronic medical illness (40%" exact="cardiovascular" post="or cerebrovascular disease). In the largest published clinical cohort"/>
  <result pre="In the largest published clinical cohort of COVID-19 to date," exact="acute" post="cardiac injury, shock, and arrhythmia were present in 7.2%,"/>
  <result pre="cohort of COVID-19 to date, acute cardiac injury, shock, and" exact="arrhythmia" post="were present in 7.2%, 8.7%, and 16.7% of patients,"/>
  <result pre="intensive care. CVDs may become unstable in the setting of" exact="viral infection" post="as a consequence of imbalance between infection-induced increase in"/>
  <result pre="care. CVDs may become unstable in the setting of viral" exact="infection" post="as a consequence of imbalance between infection-induced increase in"/>
  <result pre="increase in metabolic demand and reduced cardiac reserve. Patients with" exact="coronary artery disease" post="and heart failure may be at particular risk as"/>
  <result pre="in metabolic demand and reduced cardiac reserve. Patients with coronary" exact="artery disease" post="and heart failure may be at particular risk as"/>
  <result pre="metabolic demand and reduced cardiac reserve. Patients with coronary artery" exact="disease" post="and heart failure may be at particular risk as"/>
  <result pre="demand and reduced cardiac reserve. Patients with coronary artery disease" exact="and heart" post="failure may be at particular risk as a result"/>
  <result pre="and reduced cardiac reserve. Patients with coronary artery disease and" exact="heart" post="failure may be at particular risk as a result"/>
  <result pre="at particular risk as a result of coronary plaque rupture" exact="secondary" post="to virally induced systemic inflammation, and rigorous use of"/>
  <result pre="a result of coronary plaque rupture secondary to virally induced" exact="systemic" post="inflammation, and rigorous use of plaque stabilizing agents (aspirin,"/>
  <result pre="been suggested as a possible therapeutic strategy. Pro-coagulant effects of" exact="systemic" post="inflammation (10) may increase the likelihood of stent thrombosis"/>
  <result pre="of systemic inflammation (10) may increase the likelihood of stent" exact="thrombosis" post="and assessment of platelet function and intensified anti-platelet therapy"/>
  <result pre="a history of previous coronary intervention. The clinical effects of" exact="pneumonia" post="have been linked to increased risk of CVD up"/>
  <result pre="follow-up (11) and it is likely that cases infected via" exact="respiratory" post="virus outbreaks will experience similar adverse outcomes. Therapeutic use"/>
  <result pre="Therapeutic use of corticosteroids further augments the possibility of adverse" exact="cardiovascular" post="events. However, long-term follow-up data concerning the survivors of"/>
  <result pre="cardiovascular events. However, long-term follow-up data concerning the survivors of" exact="respiratory" post="virus epidemics are scarce. Lipid metabolism remained disrupted 12"/>
  <result pre="H7N9 influenza returned to normal at 1-year follow-up (13). Whilst" exact="viral" post="phenotype, baseline clinical characteristics, initial disease severity, and immediate"/>
  <result pre="1-year follow-up (13). Whilst viral phenotype, baseline clinical characteristics, initial" exact="disease" post="severity, and immediate management impact on short-term survival, long-term"/>
  <result pre="management impact on short-term survival, long-term prognosis following outbreaks of" exact="respiratory" post="virus infection may equally depend upon the extra-pulmonary manifestations."/>
  <result pre="impact on short-term survival, long-term prognosis following outbreaks of respiratory" exact="virus infection" post="may equally depend upon the extra-pulmonary manifestations. Serial follow-up"/>
  <result pre="on short-term survival, long-term prognosis following outbreaks of respiratory virus" exact="infection" post="may equally depend upon the extra-pulmonary manifestations. Serial follow-up"/>
  <result pre="the extra-pulmonary manifestations. Serial follow-up studies amongst the survivors of" exact="acute" post="infection are surely needed. Autopsy findings of deaths due"/>
  <result pre="extra-pulmonary manifestations. Serial follow-up studies amongst the survivors of acute" exact="infection" post="are surely needed. Autopsy findings of deaths due to"/>
  <result pre="infection are surely needed. Autopsy findings of deaths due to" exact="infection" post="with the new virus (COVID-19) revealed that mortality was"/>
  <result pre="infection with the new virus (COVID-19) revealed that mortality was" exact="lower" post="in pulmonary patients compared to cardiac patients or patients"/>
  <result pre="the new virus (COVID-19) revealed that mortality was lower in" exact="pulmonary" post="patients compared to cardiac patients or patients with diabetes,"/>
  <result pre="they indicate that, despite the adverse effects of Azithromycin (severe" exact="diarrhea" post="due to Clostridium difficile and prolonged QT interval on"/>
  <result pre="difficile and prolonged QT interval on ECG), mortality due to" exact="infection" post="with a new virus. It should be noted that"/>
  <result pre="in vitro, these agents might be used to treat COVID-19" exact="infection" post="in vivo, but it will first be necessary to"/>
  <result pre="Japan since almost 70 years ago for a number of" exact="acute" post="and chronic diseases because it has various pharmacological effect"/>
  <result pre="almost 70 years ago for a number of acute and" exact="chronic" post="diseases because it has various pharmacological effect including anti-inflamatory,"/>
  <result pre="ACE-2 receptors (16). These drugs help thousands of patients with" exact="high blood pressure," post="chronic heart failure, diabetic kidney damage and other vascular"/>
  <result pre="These drugs help thousands of patients with high blood pressure," exact="chronic" post="heart failure, diabetic kidney damage and other vascular disorders"/>
  <result pre="drugs help thousands of patients with high blood pressure, chronic" exact="heart" post="failure, diabetic kidney damage and other vascular disorders (17)."/>
  <result pre="of patients with high blood pressure, chronic heart failure, diabetic" exact="kidney damage" post="and other vascular disorders (17). Discontinuing these medicines could"/>
  <result pre="blood pressure, chronic heart failure, diabetic kidney damage and other" exact="vascular" post="disorders (17). Discontinuing these medicines could have many serious"/>
  <result pre="despite widely circulated reports that the agents could worsen coronavirus" exact="disease" post="(20). â€œIt is important that patients do not interrupt"/>
  <result pre="recently issued by the European Society of Cardiology and three" exact="American" post="cardiology societies. The medications are commonly used by patients"/>
  <result pre="societies. The medications are commonly used by patients with hypertension," exact="heart" post="failure, and kidney disease. Because the coronavirus infects human"/>
  <result pre="are commonly used by patients with hypertension, heart failure, and" exact="kidney disease." post="Because the coronavirus infects human cells by binding to"/>
  <result pre="notes. â€œThe speculation that ACE-inhibitors or ARBs treatment can make" exact="infections" post="worse in the context of COVID-19 is not supported"/>
  <result pre="and ARBs may reduce the risk for or severity of" exact="viral pneumonia" post="in patients with COVID-19 infection, or may actually have"/>
  <result pre="ARBs may reduce the risk for or severity of viral" exact="pneumonia" post="in patients with COVID-19 infection, or may actually have"/>
  <result pre="short-term treatment of fever and/or pain such as headaches, flu," exact="dental" post="pain and dysmenorrhoea (period pain). Ibuprofen is also prescribed"/>
  <result pre="(period pain). Ibuprofen is also prescribed for the treatment of" exact="arthritis" post="and rheumatic conditions. Ketoprofen is a similar medicine, mostly"/>
  <result pre="Ibuprofen is also prescribed for the treatment of arthritis and" exact="rheumatic" post="conditions. Ketoprofen is a similar medicine, mostly prescribed for"/>
  <result pre="for Medicines and Health Products Safety (ANSM) which suggested that" exact="infection" post="due to chickenpox (varicella) and some bacterial infections could"/>
  <result pre="which suggested that infection due to chickenpox (varicella) and some" exact="bacterial infections" post="could be made worse by these medicines. The product"/>
  <result pre="suggested that infection due to chickenpox (varicella) and some bacterial" exact="infections" post="could be made worse by these medicines. The product"/>
  <result pre="to provide adequate evidence on any effect of NSAIDs on" exact="disease" post="prognosis for COVID-19. The Agency is reaching out to"/>
  <result pre="protection patients with CVDs and patients with other most common" exact="chronic" post="diseases against COVID-19 infection For most people, the immediate"/>
  <result pre="and patients with other most common chronic diseases against COVID-19" exact="infection" post="For most people, the immediate risk of becoming ill"/>
  <result pre="a particular risk for people over 65 and those with" exact="chronic" post="illnesses including: cardiovascular disease, Hypertension, Diabetes, Chronic respiratory illness"/>
  <result pre="for people over 65 and those with chronic illnesses including:" exact="cardiovascular disease," post="Hypertension, Diabetes, Chronic respiratory illness and Malignancies. According to"/>
  <result pre="and those with chronic illnesses including: cardiovascular disease, Hypertension, Diabetes," exact="Chronic" post="respiratory illness and Malignancies. According to the recently published"/>
  <result pre="those with chronic illnesses including: cardiovascular disease, Hypertension, Diabetes, Chronic" exact="respiratory" post="illness and Malignancies. According to the recently published COVID-19"/>
  <result pre="According to the recently published COVID-19 Clinical Guidance for the" exact="cardiovascular" post="care team, the overall case fatality rate (CFR) of"/>
  <result pre="on published reports remains low at 2.3%, with data indicating" exact="lower" post="overall Chinese mortality outside of the outbreak epicenter in"/>
  <result pre="case reporting. Published case reports from the Chinese Centers for" exact="Disease" post="Control indicate patients with underlying comorbid conditions have a"/>
  <result pre="materially higher than the average population: Cancer: 5.6%, Hypertension: 6.0%," exact="Chronic" post="respiratory disease: 6.3%, Diabetes: 7.3% and CVD: 10.5% (21-25)."/>
  <result pre="higher than the average population: Cancer: 5.6%, Hypertension: 6.0%, Chronic" exact="respiratory" post="disease: 6.3%, Diabetes: 7.3% and CVD: 10.5% (21-25). During"/>
  <result pre="caused by the SARS COV-1 virus, the course of the" exact="disease" post="responded to acute respiratory viral infections, but a large"/>
  <result pre="SARS COV-1 virus, the course of the disease responded to" exact="acute" post="respiratory viral infections, but a large number of patients"/>
  <result pre="COV-1 virus, the course of the disease responded to acute" exact="respiratory" post="viral infections, but a large number of patients had"/>
  <result pre="virus, the course of the disease responded to acute respiratory" exact="viral" post="infections, but a large number of patients had more"/>
  <result pre="large number of patients had more severe forms of the" exact="disease" post="followed by fatal outcome (26). Mortality was significantly higher"/>
  <result pre="fatal outcome (26). Mortality was significantly higher in patients with" exact="chronic" post="comorbid conditions. Impairment in the immune response to the"/>
  <result pre="in the immune response to the virus led to severe" exact="respiratory" post="failure, which was accompanied by alveo-capillary block due to"/>
  <result pre="failure, which was accompanied by alveo-capillary block due to the" exact="diffuse" post="inflammation of the alveolar and vascular structures of the"/>
  <result pre="block due to the diffuse inflammation of the alveolar and" exact="vascular" post="structures of the lung, as the bodyâ€™s immune system"/>
  <result pre="alveolar activation and surfactant inactivation. This condition is known as" exact="Acute" post="Respiratory Distress Syndrome (ARDS) and requires the respirator application"/>
  <result pre="activation and surfactant inactivation. This condition is known as Acute" exact="Respiratory" post="Distress Syndrome (ARDS) and requires the respirator application (26)."/>
  <result pre="surfactant inactivation. This condition is known as Acute Respiratory Distress" exact="Syndrome" post="(ARDS) and requires the respirator application (26). Death is"/>
  <result pre="leading to more severe forms of ARDS. After it causes" exact="respiratory" post="symptoms, the virus infects all other organ systems (cardiovascular,"/>
  <result pre="used by the virus to enter the cells of the" exact="respiratory" post="system for reproduction, also have other organs, which can"/>
  <result pre="as cytokines, and cause â€œcytokine stormâ€� (27). Patients with COVID-19" exact="infection" post="have, in addition to the symptoms of acute respiratory"/>
  <result pre="with COVID-19 infection have, in addition to the symptoms of" exact="acute" post="respiratory infection, clinical signs of other diseases. Cases with"/>
  <result pre="COVID-19 infection have, in addition to the symptoms of acute" exact="respiratory" post="infection, clinical signs of other diseases. Cases with clinical"/>
  <result pre="signs of other diseases. Cases with clinical presentation of active" exact="gastroenterocolitis" post="with predominance of diarrhea and bleeding have been described."/>
  <result pre="Cases with clinical presentation of active gastroenterocolitis with predominance of" exact="diarrhea" post="and bleeding have been described. Initial autopsy and biopsy"/>
  <result pre="clinical presentation of active gastroenterocolitis with predominance of diarrhea and" exact="bleeding" post="have been described. Initial autopsy and biopsy reports of"/>
  <result pre="various tissues indicate pathological changes in almost all organ systems." exact="Blood" post="tests of patients with COVID-19 almost always show haematological"/>
  <result pre="the virus. The question of the future course of the" exact="disease" post="remains unanswered, given the possibility of mutation. Patients with"/>
  <result pre="reinfection and persistent carriers of the virus (similar to B" exact="hepatitis" post="positive) (26). The current major challenge for public health"/>
  <result pre="technologies and pharmacological agents and drugs in the treatment of" exact="viral" post="infections such as COVID-19. This global pandemic infection has"/>
  <result pre="and pharmacological agents and drugs in the treatment of viral" exact="infections" post="such as COVID-19. This global pandemic infection has just"/>
  <result pre="treatment of viral infections such as COVID-19. This global pandemic" exact="infection" post="has just shown how dysplosion of the use of"/>
  <result pre="sought infected, but also recorded the number of people with" exact="chronic" post="diseases, potential for infection and possible lethal outcome. In"/>
  <result pre="recorded the number of people with chronic diseases, potential for" exact="infection" post="and possible lethal outcome. In this case the community"/>
  <result pre="a key role in preventing the massive spread of COVID-19" exact="infection" post="demonstrated the importance and value of the public health"/>
  <result pre="appropriate treatment of a large number of patients with massive" exact="chronic" post="non-communicable diseases, adhering to the principle of the many"/>
  <result pre="FOR PREVENTION COVID-19 ON WEB SITES The U.S. Centers for" exact="Disease" post="Control and Prevention has developed interim guidance for businesses"/>
  <result pre="interim guidance is intended to help prevent workplace exposures to" exact="acute" post="respiratory illnesses, including COVID-19. Older adults and those with"/>
  <result pre="guidance is intended to help prevent workplace exposures to acute" exact="respiratory" post="illnesses, including COVID-19. Older adults and those with underlying"/>
  <result pre="respiratory illnesses, including COVID-19. Older adults and those with underlying" exact="chronic" post="medical conditions seem to be at higher risk, according"/>
  <result pre="cleaning and disinfecting frequently touched surfaces can help prevent coronavirus" exact="infections" post="are the main proposal of WHO experts. Those preventive"/>
  <result pre="not yet been reported. As such, phisycians who work at" exact="primary" post="health care level should assume it could already be"/>
  <result pre="dining; and implement active screening of residents for fever and" exact="respiratory" post="symptoms, especially older adults often with underlying chronic medical"/>
  <result pre="fever and respiratory symptoms, especially older adults often with underlying" exact="chronic" post="medical conditions, including patients with CVD, who are at"/>
  <result pre="of being affected by COVID-19. COVID-19 spreads by contact with" exact="respiratory" post="droplets that spread when an infected person coughs or"/>
  <result pre="cleaning and disinfecting frequently touched surfaces can help prevent coronavirus" exact="infections" post="(22-24). The general strategies CDC recommends to prevent the"/>
  <result pre="every day to detect and prevent the spread of other" exact="respiratory" post="viruses like influenza (25). COVID-19 is being increasingly reported"/>
  <result pre="facilities. This information complements, but does not replace, the general" exact="infection" post="prevention and control recommendations for COVID-19 (25). Current guidance"/>
  <result pre="(25). Unfortunately, publich health sector in our country is still" exact="limited" post="to be effective like it was in previously organized"/>
  <result pre="and improve your immunity system. Especially patients registered with CVD," exact="Diabetes mellitus," post="cancers, and respiratory diseases. But, the fact is that"/>
  <result pre="system. Especially patients registered with CVD, Diabetes mellitus, cancers, and" exact="respiratory" post="diseases. But, the fact is that current focus of"/>
  <result pre="virus circulation: a modelling studyLancet Infect Dis20121268769522738893 3.XiongTian-YuanRedwoodSimonPrendergastBernardChenMaoCoronaviruses and the" exact="cardiovascular" post="system: acute and long-term implicationsEuropean Heart Journal202011310.1093/eurheartj/ehaa231 4.NguyenJLYangWItoKMatteTDShamanJKinneyPLSeasonal influenza"/>
  <result pre="a modelling studyLancet Infect Dis20121268769522738893 3.XiongTian-YuanRedwoodSimonPrendergastBernardChenMaoCoronaviruses and the cardiovascular system:" exact="acute" post="and long-term implicationsEuropean Heart Journal202011310.1093/eurheartj/ehaa231 4.NguyenJLYangWItoKMatteTDShamanJKinneyPLSeasonal influenza infections and"/>
  <result pre="Dis20121268769522738893 3.XiongTian-YuanRedwoodSimonPrendergastBernardChenMaoCoronaviruses and the cardiovascular system: acute and long-term implicationsEuropean" exact="Heart" post="Journal202011310.1093/eurheartj/ehaa231 4.NguyenJLYangWItoKMatteTDShamanJKinneyPLSeasonal influenza infections and cardiovascular disease mortalityJAMA Cardiol2016127427438105"/>
  <result pre="cardiovascular system: acute and long-term implicationsEuropean Heart Journal202011310.1093/eurheartj/ehaa231 4.NguyenJLYangWItoKMatteTDShamanJKinneyPLSeasonal influenza" exact="infections" post="and cardiovascular disease mortalityJAMA Cardiol2016127427438105 5.KhotWYNadkarMYThe 2019 Novel Coronavirus"/>
  <result pre="acute and long-term implicationsEuropean Heart Journal202011310.1093/eurheartj/ehaa231 4.NguyenJLYangWItoKMatteTDShamanJKinneyPLSeasonal influenza infections and" exact="cardiovascular disease" post="mortalityJAMA Cardiol2016127427438105 5.KhotWYNadkarMYThe 2019 Novel Coronavirus Outbreakâ€&quot;A Global ThreatJ"/>
  <result pre="and long-term implicationsEuropean Heart Journal202011310.1093/eurheartj/ehaa231 4.NguyenJLYangWItoKMatteTDShamanJKinneyPLSeasonal influenza infections and cardiovascular" exact="disease" post="mortalityJAMA Cardiol2016127427438105 5.KhotWYNadkarMYThe 2019 Novel Coronavirus Outbreakâ€&quot;A Global ThreatJ"/>
  <result pre="Assoc Physicians India2020686771 6.BadawiARyooSGPrevalence of comorbidities in the Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV): a systematic review and meta-analysisInt J"/>
  <result pre="Physicians India2020686771 6.BadawiARyooSGPrevalence of comorbidities in the Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV): a systematic review and meta-analysisInt J Infect"/>
  <result pre="J Infect Dis20164912913327352628 7.LiSSChengCFuCChanYLeeMChanJWYiuSLeft ventricular performance in patients with severe" exact="acute" post="respiratory syndrome: a 30-day echocardio-graphic follow-up studyCirculation20031081798180314504188 8.HarrisJEShahPJKorimilliVWinHFrequency of"/>
  <result pre="Infect Dis20164912913327352628 7.LiSSChengCFuCChanYLeeMChanJWYiuSLeft ventricular performance in patients with severe acute" exact="respiratory" post="syndrome: a 30-day echocardio-graphic follow-up studyCirculation20031081798180314504188 8.HarrisJEShahPJKorimilliVWinHFrequency of troponin"/>
  <result pre="follow-up studyCirculation20031081798180314504188 8.HarrisJEShahPJKorimilliVWinHFrequency of troponin elevations in patients with influenza" exact="infection" post="during the 2017-2018 influenza seasonInt J Cardiol Heart Vasc20192214514730740511"/>
  <result pre="with influenza infection during the 2017-2018 influenza seasonInt J Cardiol" exact="Heart" post="Vasc20192214514730740511 9.WangDHuBHuCZhuFLiuXZhangJet al.Clinical characteristics of 138 hospitalized patients with"/>
  <result pre="al.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected" exact="pneumonia" post="in Wuhan, ChinaJAMA202010.1001/jama.2020.1585 10.LibbyPSimonDIInflammation and thrombosis: the clot thickensCirculation20011031718172011282900"/>
  <result pre="10.LibbyPSimonDIInflammation and thrombosis: the clot thickensCirculation20011031718172011282900 11.Corrales-MedinaVFAlvarezKNWeissfeldLAAngusDCChirinosJAChangCCNewmanALoehrLFolsomARElkindMSLylesMFKronmalRAYendeSAssociation between hospitalization for" exact="pneumonia" post="and subsequent risk of cardiovascular diseaseJAMA201531326425602997 12.WuQZhouLSunXYanZHuCWuJet al.Altered lipid"/>
  <result pre="thickensCirculation20011031718172011282900 11.Corrales-MedinaVFAlvarezKNWeissfeldLAAngusDCChirinosJAChangCCNewmanALoehrLFolsomARElkindMSLylesMFKronmalRAYendeSAssociation between hospitalization for pneumonia and subsequent risk of" exact="cardiovascular" post="diseaseJAMA201531326425602997 12.WuQZhouLSunXYanZHuCWuJet al.Altered lipid metabolism in recov-ered SARS patients"/>
  <result pre="COVID-19: Clinical Guidance For the CV Care Team20203March 15th, 2020The" exact="American" post="College of CardiologyAvailable on: http://www.acc.org/~/media/665AFA1E710B4B3293138D14BE8D1213.pdf 22.March 15th, 2020http://www.drugs.com/condition/covid-19.html 23.March"/>
  <result pre="23.March 15th, 2020http://www.cdc.gov/coronavirus/2019-ncov/infection-control/index.html 24.March 15th, 2020https://www.healthline.com/health/coronavirus-covid-19#symptoms 25.March 15th, 2020https://www.bing.com/search?q=prevention+covid-19&amp;amp;form=PREXEN 26.SalihefendicNZildzicMAhmetagicSAcute" exact="Respiratory" post="Distress Syndrome (ARDS) from Endemic Influenza A/H1N1: Prehospital ManagementMed"/>
  <result pre="2020http://www.cdc.gov/coronavirus/2019-ncov/infection-control/index.html 24.March 15th, 2020https://www.healthline.com/health/coronavirus-covid-19#symptoms 25.March 15th, 2020https://www.bing.com/search?q=prevention+covid-19&amp;amp;form=PREXEN 26.SalihefendicNZildzicMAhmetagicSAcute Respiratory Distress" exact="Syndrome" post="(ARDS) from Endemic Influenza A/H1N1: Prehospital ManagementMed Arh201526916263 27.HassanSJawadJMAhjelWSSingBRSingJAwadMSHadiRNThe"/>
 </snippets>
</snippetsTree>
